Sign in
Taking people in United StatesNo phase

Home Cycling Exercise for Multiple Sclerosis and High Blood Pressure

Tests home cycling against home stretching in adults with multiple sclerosis and high blood pressure.

Key facts

Who runs it
University of Massachusetts, Boston
Where
Boston, United StatesSee the site
Trial code
Registry title
Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
Status
Recruiting
People taking part
80 people, planned
Started
15 Apr 2025
Expected to end
Aug 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Home-based aerobic training
Record updated
22 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with multiple sclerosis and high blood pressure who are not very active. It tests home cycling exercise against home stretching for 12 weeks.

Age
18 Years or older
Sex
All sexes can join.
Disease stage
Confirmed multiple sclerosis with Expanded Disability Status Scale scores of 4-6.5. High blood pressure: elevated, or Stage 1 or 2 (systolic above 120 mmHg or diastolic above 80 mmHg).
Earlier treatment
Stable medicines are asked for. People must be physically inactive (less than 60 min/wk of physical activity).

Main reasons for not taking part

  • Other heart or blood vessel conditions
  • Type 1 diabetes
  • Body mass index of 40 kg/m2 or more
  • Confined to a wheelchair
  • No space at home for a cycle ergometer

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Persons with confirmed multiple sclerosis diagnosis with Expanded Disability Status Scale scores of 4-6.5, characteristic of 2nd stage of multiple sclerosis
  • Hypertension defined as elevated, or Stage 1 or 2, as per the 2017 American Heart Association guidelines (brachial systolic blood pressure > 120 mmHg or brachial diastolic blood pressure > 80 mmHg)
  • Persons who are physically inactive (less than 60 min/wk of physical activity)
  • Persons with body mass index < 40 kg/m2
  • Persons who are not confined to a wheel chair
  • Multiple sclerosis relapse in the past 30 days
  • People with stable pharmacotherapy

Who cannot take part

  • People with type 1 diabetes mellitus
  • People with additional cardiovascular comorbidities
  • Physician disapproval to participating in the study
  • Space constraints to fit a cycle ergometer at the home of prospective participants

Where in United States

  • UMass BostonBoston, United StatesContact: Tracy Baynard, PhDTaking people

About the trial

What the trial wants to find out

The goal of this study is to determine if 12 weeks of cycling exercise training at home will improve three parameters: 1) blood pressure, 2) cognition, and 3) walking ability among persons with multiple sclerosis who have high blood pressure, when compared to a group that engages in a 12-week home-based stretching program.

Read full original descriptionShow less

The main questions this study aims to answer are:

1. Can home-based cycling exercise training improve blood pressure by increasing blood vessel dilation in people with multiple sclerosis? 2. Can cycling exercise training improve cognition and walking mobility in people with multiple sclerosis by improving blood pressure?

The investigators will compare home-based cycling training to stretching to see if cycling training improves cognition, walking mobility, blood pressure, and fitness in people with multiple sclerosis.

Participation in this study will take 13-14 weeks, with participants being randomized (like flipping a coin, a 50-50 chance of being in either group) to the home-based cycling training or the stretching group.

All participants will be asked to

* Visit the laboratory two times, one before the beginning of the intervention (home-base training and stretching group) and one at the end of the intervention. * During visits, participants will complete tests related to cognition, walking mobility, blood pressure and fitness.

The 2 groups in the trial

  • Home-based aerobic trainingTreatment being tested

    A 3-month home-based exercise training intervention comprising cycle ergometry as an aerobic mode of training coupled with behavioral coaching. The regimen will be delivered 3-4 days per week.

  • Attention controlNo study treatment, for comparison

    The alternative treatment condition comprises a stretching program with minimal exercise and attention control. This program will be delivered using the same frequency and duration as the intervention. The first session will be conducted under the supervision of visiting study personnel as described above. The stretching exercises will follow the manual provided by the National Multiple Sclerosis Society and the investigators will progressively include more exercises and sets over the 3 months, this too has been standardized and manualized for reproducibility. The investigators will provide the same materials and Internet coaching for the attention control group as for the intervention group but focused on stretching and not on increasing aerobic exercise. The investigators will ask that participants not undertake additional exercise during the study duration and this will be documented through an exercise history, the Godin Leisure-Time Exercise Questionnaire.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Targeting Vascular Mechanisms of Functional Outcomes Via Home-based Exercise Training Among Persons With Multiple Sclerosis Who Have Hypertension
Plain-language title
Home Cycling Exercise for Multiple Sclerosis and High Blood PressureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
22 August 2025